Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 841-850 of 9364

Page
per page
  1. PD-1/PD-L1 inhibitor 2
    B6023 PD-1/PD-L1 inhibitor 2
    Target: PD-1/PD-L1 interaction
    Summary: PD-1/PD-L1 interaction inhibitor
      ≥42 mg/mL
  2. DEL-22379
    B6024 DEL-22379
    Summary: inhibitor of the dimerization of ERK
      Soluble in DMSO
  3. DASA-58
    B6025 DASA-58
    Summary: activator of pyruvate kinase M2 (PKM2)
      insoluble in EtOH; insoluble in H2O; ≥127.2 mg/mL
  4. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
  5. Napabucasin
    B6029 Napabucasin
    Target: STAT
    Summary: STAT3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL
  6. SKF38393 HCl
    B6030 SKF38393 HCl
    Summary: dopamine D1 receptor agonist
      ≥29.2 mg/mL
  7. GMX1778 (CHS828)
    B6031 GMX1778 (CHS828)
    Summary: NAMPT inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.3 mg/mL
  8. Beauvericin
    B6113 Beauvericin
    Summary: antibacterial and antifungal activities
      Soluble in DMSO
  9. CBR-5884
    A8721 CBR-5884
     1 Citation
    Target: 3-phosphoglycerate dehydrogenase
    Summary: selective inhibitor of PHGDH
      insoluble in EtOH; insoluble in H2O; ≥16.8 mg/mL
  10. GSK180
    A8723 GSK180
    Target: Kynurenine-3-monooxygenase
    Summary: inhibitor of kynurenine-3-monooxygenase (KMO)
      ≥27.6 mg/mL

Items 841-850 of 9364

Page
per page